Hikma Pharmaceuticals PLC (HIK) — Financial Flexibility Index
Hikma Pharmaceuticals PLC (HIK) has a Financial Flexibility Index of 0.08x as of June 2025. Free cash flow of GBX229.00 Million (operating CF GBX161.00 Million minus capex GBX68.00 Million) represents 0% of total liabilities (GBX3.00 Billion). Check Hikma Pharmaceuticals PLC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hikma Pharmaceuticals PLC Financial Flexibility Index (2002–2024)
Historical Financial Flexibility Index trend for Hikma Pharmaceuticals PLC across 23 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Hikma Pharmaceuticals PLC.
Annual Financial Flexibility Index for Hikma Pharmaceuticals PLC (2002–2024)
Year-by-year free cash flow to debt coverage for Hikma Pharmaceuticals PLC. Explore HIK operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.26x | GBX729.00 Million | GBX564.00 Million | GBX2.81 Billion | ▼ -17.6% |
| 2023 | 0.31x | GBX777.00 Million | GBX608.00 Million | GBX2.47 Billion | ▼ -3.3% |
| 2022 | 0.33x | GBX755.00 Million | GBX530.00 Million | GBX2.32 Billion | ▼ -28.6% |
| 2021 | 0.46x | GBX867.00 Million | GBX638.00 Million | GBX1.91 Billion | ▲ +31.4% |
| 2020 | 0.35x | GBX688.00 Million | GBX464.00 Million | GBX1.99 Billion | ▼ -5.2% |
| 2019 | 0.37x | GBX658.00 Million | GBX472.00 Million | GBX1.80 Billion | ▲ +22.5% |
| 2018 | 0.30x | GBX537.00 Million | GBX430.00 Million | GBX1.80 Billion | ▲ +0.9% |
| 2017 | 0.30x | GBX550.00 Million | GBX443.00 Million | GBX1.86 Billion | ▲ +39.1% |
| 2016 | 0.21x | GBX415.00 Million | GBX293.00 Million | GBX1.95 Billion | ▼ -40.9% |
| 2015 | 0.36x | GBX448.00 Million | GBX366.00 Million | GBX1.25 Billion | ▼ -27.8% |
| 2014 | 0.50x | GBX516.00 Million | GBX425.00 Million | GBX1.03 Billion | ▲ +12.7% |
| 2013 | 0.44x | GBX396.00 Million | GBX337.00 Million | GBX895.00 Million | ▲ +43.3% |
| 2012 | 0.31x | GBX272.35 Million | GBX182.16 Million | GBX882.26 Million | ▲ +32.8% |
| 2011 | 0.23x | GBX180.64 Million | GBX102.64 Million | GBX777.01 Million | ▼ -55.7% |
| 2010 | 0.53x | GBX191.98 Million | GBX138.79 Million | GBX365.52 Million | ▲ +22.2% |
| 2009 | 0.43x | GBX145.90 Million | GBX105.52 Million | GBX339.46 Million | ▲ +24.5% |
| 2008 | 0.35x | GBX123.39 Million | GBX57.87 Million | GBX357.46 Million | ▲ +65.2% |
| 2007 | 0.21x | GBX98.11 Million | GBX43.12 Million | GBX469.38 Million | ▼ -64.9% |
| 2006 | 0.59x | GBX82.43 Million | GBX29.99 Million | GBX138.56 Million | ▲ +15.9% |
| 2005 | 0.51x | GBX56.70 Million | GBX32.71 Million | GBX110.48 Million | ▼ -4.0% |
| 2004 | 0.53x | GBX54.17 Million | GBX32.84 Million | GBX101.31 Million | ▲ +67.3% |
| 2003 | 0.32x | GBX18.35 Million | GBX18.35 Million | GBX57.39 Million | ▲ +4.3% |
| 2002 | 0.31x | GBX14.35 Million | GBX14.35 Million | GBX46.84 Million | — |